News
News Center
2021-03-08
Li Zhenguo, a deputy to the National People's Congress and Chairman of Jiuzhitang, proposed advancing the high-quality development of traditional Chinese medicine, strengthening the public health security system to safeguard people's health and safety, accelerating the translation of stem-cell technologies into viable pharmaceutical products, fostering rapid, high-quality growth in the industry, and promoting the effective integration of traditional medicine with precision medicine.
+
2021-03-04
With the Two Sessions approaching, several representatives and committee members have offered valuable suggestions for advancing the stem cell industry. This initiative is set to accelerate the development of China's stem cell sector, expedite its clinical translation, and ultimately meet patients' needs while enhancing the health and well-being of people nationwide—providing significant momentum for the field.
+
2021-01-29
Shanghai CPPCC members have suggested that Shanghai should leverage its advantageous resources to take the lead in piloting initiatives, accelerating the clinical translation of stem cell research and fostering its industrialization.
+
2020-12-28
Why do we age? It’s due to the declining ability of cells to coordinate effectively.
As time passes, what actually declines in the human body is cellular coordination—not cellular function. This groundbreaking research holds promise for offering new approaches to treating aging.
+
2020-12-15
As research into the disease mechanisms of stem cell therapy progresses, stem cells have demonstrated promising therapeutic effects across a wide range of medical conditions. Currently, they are already being used to treat more than 200 challenging and complex diseases, offering newfound hope to patients struggling with rare illnesses. Looking ahead, with the continued advancement of regenerative medicine, the clinical translation and implementation of stem cell therapies for diabetes and its associated complications are expected to become a reality sooner rather than later.
+
2020-12-14
CCTV: Stem cell technology helps the "Noodle Brothers" stand tall again.
Twins were diagnosed with the same rare disease, dubbed "Noodle Men," medically known as "Super Cancer," which left them paralyzed at age twelve and ultimately claimed their lives by age eighteen. Their parents embarked on a grueling journey across China, tirelessly searching for a life-saving cure. Thanks to groundbreaking stem-cell therapy, the brothers are now able to walk normally again—giving them a renewed chance at life.
+
2020-12-01
World AIDS Day | The Complete Process of Stem Cell Therapy for HIV/AIDS
When AIDS is mentioned, many people feel panicked—and some even associate it directly with death. In recent years, the groundbreaking cases of "the Berlin Patient" and "the London Patient," both cured of HIV through stem cell therapy, have captured global attention, offering new hope to AIDS patients while also providing valuable lessons and guidance for future clinical applications of similar treatments. Today, let’s explore together how stem cells are being used to treat HIV/AIDS.
+
2020-10-23
Patient good news! Stem cell therapy is safe and effective for treating osteoarthritis!
Extensive clinical research data, both domestically and internationally, has confirmed that stem cell therapy is safe and effective in treating knee osteoarthritis. Stem cell therapy significantly improves joint pain symptoms and functional impairments in patients with knee osteoarthritis, while also demonstrating promising long-term benefits, making it a treatment approach with vast potential. For the growing number of arthritis patients, stem cell therapy offers new hope for recovery. We look forward to even more robust research and groundbreaking advancements in cellular treatment technologies!
+
2020-09-25
Big news! The Beijing Institute of Stem Cell and Regenerative Medicine has been established in Beijing. The institute is a new R&D institution jointly built by the Beijing Municipal Government and the Chinese Academy of Sciences.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy